Engin Yapici·Jun 16PPIFlow: Picomolar Binder Design and the Limits of the BLI DataChangping Laboratory’s flow-matching pipeline reports picomolar affinities for six of seven mini-binder targets, all measured by BLI.
Engin Yapici·Apr 21I Stress-Tested the AWS-MSK Nanobody Paper. These Are the Gaps.Technical analysis of an agent-guided de novo nanobody design campaign
Engin Yapici·Feb 24Germinal: Open-Source Nanobody Design With Epitope Evidence and Some Unresolved GapsStanford and Arc Institute’s pipeline designs nanobodies against specified epitopes, testing only 43–101 candidates per target.
Engin Yapici·Feb 3I Went Through BindCraft’s Affinity Data. Here Are the Gaps I Found.65 binders from 212 designs. Only 20 have KD measurements.
Engin Yapici·Jan 20Origin-1: Absci’s De Novo Antibody Design PlatformMicromolar hits with structural validation but therapeutic gaps.
Engin Yapici·Jan 14RFdiffusion3: Atom-Level Protein Design at ScaleBaker Lab released RFdiffusion3, an all-atom diffusion model for designing proteins that interact with DNA, ligands, and other…
Engin Yapici·Dec 30, 2025Low Immunogenicity in Human Panels? Examining Latent-X2’s EvidenceAnalyzing the immunogenicity assay quality and binding validation in the first AI antibody study to test human immune responses
Engin Yapici·Dec 16, 2025Analyzing BoltzGen: MIT’s Multi-Target Binder Design ModelMIT released BoltzGen for computational binder design in collaboration with multiple academic labs and Adaptyv Bio*. The model handles…A response icon2A response icon2
Engin Yapici·Dec 2, 2025JAM-2: Performance Metrics and Validation GapsTechnical analysis of Nabla Bio’s computational antibody design platform
Engin Yapici·Nov 25, 2025I Tried to Poke Holes in Chai-2’s Antibody Design Paper. Here’s What I Found.88 designed antibodies, atomic accuracy, and some important caveats.